2 Clarke Drive
Suite 100
Cranbury, NJ 08512
© 2024 MJH Life Sciences™ and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.
James Knight, MD, discusses the potential launch of a case series of patients with brain-metastatic prostate adenocarcinoma.
James Knight, MD, resident, Radiation Medicine, the University of Kentucky College of Medicine, discusses the potential launch of a case series of patients with brain-metastatic prostate adenocarcinoma, highlighting the importance of the continued research regarding additional biomarkers which may improve the treatment landscape.
Related Content: